Modulating effect of new potential antimelanomic agents, spin-labeled triazenes and nitrosoureas on the dopa-oxidase activity of tyrosinase

Cancer Biochemistry Biophysics

Volumn 17, Issue 1-2, 1999, Pages 99-108

  Gadjeva, Vesselina ^a   Zheleva, Antoaneta ^a   Raikova, Elena ^a  

^a TRAKIA UNIVERSITY   (Bulgaria)

Author keywords

DOPA oxidase; Malignant melanoma; Nitrosoureas; Spin labeled; Triazenes; Tyrosinase

Indexed keywords

ALKYLATING AGENT; AMINE OXIDE; DACARBAZINE; DOPA; ENZYME INHIBITOR; LOMUSTINE; MONOPHENOL MONOOXYGENASE; NITROSOUREA DERIVATIVE; PIPERIDINE DERIVATIVE; TRIAZENE DERIVATIVE; TUMOR PROTEIN; VEGETABLE PROTEIN;

ANIMAL; ARTICLE; CATALYSIS; CELL CULTURE; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; ENZYMOLOGY; EXPERIMENTAL MELANOMA; METABOLISM; MOUSE; OXIDATION REDUCTION REACTION; SPECTROPHOTOMETRY; SPIN LABELING; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CATALYSIS; CYCLIC N-OXIDES; DACARBAZINE; DIHYDROXYPHENYLALANINE; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; LOMUSTINE; MELANOMA, EXPERIMENTAL; MICE; MOLECULAR STRUCTURE; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; NITROSOUREA COMPOUNDS; OXIDATION-REDUCTION; PIPERIDINES; PLANT PROTEINS; SPECTROPHOTOMETRY; SPIN LABELS; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZENES; TUMOR CELLS, CULTURED;

EID: 0032829821     PISSN: 03057232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Burnett, J. B., Seiler, H. and Brown, I. (1967) Separation and characterization of multiple forms of tyrosinase from mouse melanoma. Cancer Res., 27, 880.
2. Cornis, R. L. and S. K. Carter (1974). Integration of chemotherapy into combined modality therapy of solid tumors IV Malignant melanoma. Cancer Treat. Rev. 1, 285.
3. Gadzheva, V., K. Ichimori, H. Nakazawa and Z. Raikov (1994). Superoxide scavenging activity of spin labeled nitrosourea and triazene derivatives. Free Rad. Res. 21, 177.
4. Gesher, A. and M.D Threadgill (1987). The metabolism of triazene antitumor drugs. Pharmac. Ther. 32, 191.
5. Ilarionova, M., D. K Todorov, A. Zheleva and Z. Raikov (1993a). Third generation potential antimelanomic drugs. Oncologia 30, suppl. 1, 73.
6. Ilarinova, M. V., A M Zheleva, Z. D. Raikov, D. K. Todorov, A. P. Dudov (1993b). Nitrosourea antitumor agents-correlation between antitumor action and some biochemical properties of newly synthesizes derivatives. J. Chemother. 5, suppl. 1, 786.
7. Ilarionova, M., D. Todorov, Z. Raikov, G. Demirov et al (1985). Experimental studies of some antitumor nitrosoureas. CMEA Chemotherapy Symposium, Seckhardt, S. Kerpel-Froinus (Eds.). Budapest Akademia Kiado, 435.
8. Kann, H. E. (1981). Carbamoylating activity of nitrosoureas in A. W. Prestayko, S. T. Grooke, L. H. Baker, S. K. Carter and P. S. Shein, (Eds.). Nitrosoureas: current status and new developments, Academic Press, New York. pp. 95-104.
9. 6-alkylguanine-DNA alkyltransferase in human peripheral leukocytes. Cancer Res. 54, 4072.
10. Pyrhonen, S., M. Hahka-Kemppinen and T. Muhonen (1992). A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma. J. Clin. Oncol. 10, 1919.
11. Rachkova, M., E. Raikova and Z. Raikov (1991). New nitrosoureas and their spin-labeled derivatives influence DOPA - oxidase activity of tyrosinase. Cancer Biochem. Biophys. 12, 59.
12. Raikov, Z. D., P. M. Blagoeva, N. D. Yordanov (1979). Quantitative investigation with EPR of TMPO in homogenates from tissues of hamsters with transplanted melanomic malignant melanoma. Pigment Cell 5, 210
13. Raikov, Z.D., P. M. Blagoeva and N. D. Yordanov (1976). Activating effect of 2,2,6,6-tetramethyl-4-oxypiperidine-1-oxyl on tyrosinase ex mushroom. Compt. Rend. Acad. Bulg. Sci 29, 709.
14. Raikov, Z., V. Gadzheva, M. Koch and G. Kolar (1993). Synthesis of spin-labeled triazenes. OPPI 25, 473.
15. Vorobiof, D. A. and G. Falkson (1982). Metastatic malignant melanoma. Cancer Ther. Update 11, 3.
16. Zheleva, A., Z. Raikov, M. Ilarionova, B. Carpenter, D. Todorov and N. Armstrong (1996). Potential antimelanomic drugs 1. Synthesis and antimelanomic effect of a spin labeled D,L-aminoacid containing a 2-chloroethylnitrosocarbamoyl group. Pharmazie 51, 602.